Company / Operating Income
Illumina, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$807.0M
FY2025
5-year range
-$1.1B / $807.0M
FY2021-FY2025
Trend
+196.9%
vs FY2024
Sector context
#32 of 156
Health Care
What the data says
Illumina, Inc.'s operating income of $807M is higher than 79% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 10 years, ranging from -$1.1B in FY2023 to $807M in FY2025.
Based on SEC 10-K filings.
$807M in FY2025 with a 5-year CAGR of +6.8%. Top quartile in the Health Care sector.
Improved from -$1.1B to $807M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +11.6%
- 5-Year CAGR
- +6.8%
- 10-Year CAGR
- -
Sector benchmark
+10.1% above sector average
Key checks
Key Insights
- 5-year CAGR of +6.8%, indicating consistent growth.
- In FY2025, operating income increased 196.9% year-over-year.
- Ranks #32 out of 156 companies in the Health Care sector.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $807.0M | +196.9% |
| FY2024 | -$833.0M | +22.1% |
| FY2023 | -$1.1B | -284.3% |
| FY2022 | $580.0M | +571.5% |
| FY2021 | -$123.0M | -121.2% |
| FY2020 | $580.0M | -4.3% |
| FY2019 | $606.0M | +3.2% |
| FY2018 | $587.0M | -4.2% |
| FY2017 | $613.0M | +4.4% |
| FY2016 | $587.0M | -4.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026